[Different Prophylaxis Strategies for Central Nervous System Recurrence of Diffuse Large B-Cell Lymphoma].

Compared with HD-MTX, lenalidomide combined with immunochemotherapy can prevent CNS relapse, at the same time, improve prognosis, which is a safe and well tolerated central prophylaxis strategy.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2024-10-01
DOI
https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.05.015
Primary Topic
CNS Lymphoma Diagnosis and Treatment
Type
article
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[Different Prophylaxis Strategies for Central Nervous System Recurrence of Diffuse Large B-Cell Lymphoma].

Jiesong Wang, Shuang Qu, Lisheng Liao, Hongming He et al.
1 links
PubMed
CNS Lymphoma Diagnosis and Treatment
article

[Different Prophylaxis Strategies for Central Nervous System Recurrence of Diffuse Large B-Cell Lymphoma].

Jiesong Wang, Shuang Qu, Lisheng Liao, Hongming He, Yanbin Zheng, Hong Sun, Biyun Chen
article en

Abstract

Compared with HD-MTX, lenalidomide combined with immunochemotherapy can prevent CNS relapse, at the same time, improve prognosis, which is a safe and well tolerated central prophylaxis strategy.

PubMedVol. 32(5)
Fujian Medical University (CN), Fujian Provincial Hospital (CN), Fujian Provincial Cancer Hospital (CN)
CNS Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.